Logo image
A New Family of Small-Molecule CD4-Mimetic Compounds Contacts Highly Conserved Aspartic Acid 368 of HIV-1 gp120 and Mediates Antibody-Dependent Cellular Cytotoxicity
Journal article   Open access   Peer reviewed

A New Family of Small-Molecule CD4-Mimetic Compounds Contacts Highly Conserved Aspartic Acid 368 of HIV-1 gp120 and Mediates Antibody-Dependent Cellular Cytotoxicity

Shilei Ding, Melissa C Grenier, William D Tolbert, Dani Vézina, Rebekah Sherburn, Jonathan Richard, Jérémie Prévost, Jean-Philippe Chapleau, Gabrielle Gendron-Lepage, Halima Medjahed, …
Journal of virology, v 93(24)
15 Dec 2019
PMID: 31554684
url
https://doi.org/10.1128/jvi.01325-19View
Published, Version of Record (VoR)Open Access (License Unspecified) Open
url
https://doi.org/10.1128/JVI.01325-19View
Published, Version of Record (VoR) Open

Abstract

Antibodies, Neutralizing Antibody-Dependent Cell Cytotoxicity - immunology Aspartic Acid CD4 Antigens - chemistry CD4 Antigens - metabolism CD4-Positive T-Lymphocytes - virology Epitopes - immunology HEK293 Cells HIV Envelope Protein gp120 - chemistry HIV Envelope Protein gp120 - immunology HIV Infections - virology HIV-1 - immunology Humans Models, Molecular Protein Binding Protein Conformation Virion
The HIV-1 envelope glycoprotein (Env) trimer mediates virus entry into cells. The "closed" conformation of Env is resistant to nonneutralizing antibodies (nnAbs). These antibodies mostly recognize occluded epitopes that can be exposed upon binding of CD4 or small-molecule CD4 mimetics (CD4mc). Here, we describe a new family of small molecules that expose Env to nnAbs and sensitize infected cells to antibody-dependent cellular cytotoxicity (ADCC). These compounds have a limited capacity to inhibit virus infection directly but are able to sensitize viral particles to neutralization by otherwise nonneutralizing antibodies. Structural analysis shows that some analogs of this family of CD4mc engage the gp120 Phe43 cavity by contacting the highly conserved D368 residue, making them attractive scaffolds for drug development. HIV-1 has evolved multiple strategies to avoid humoral responses. One efficient mechanism is to keep its envelope glycoprotein (Env) in its "closed" conformation. Here, we report on a new family of small molecules that are able to "open up" Env, thus exposing vulnerable epitopes. This new family of molecules binds in the Phe43 cavity and contacts the highly conserved D368 residue. The structural and biological attributes of molecules of this family make them good candidates for drug development.

Metrics

13 Record Views
25 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Virology
Logo image